NCT05828966View on ClinicalTrials.gov

HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 15, 2023

Primary Completion Date

May 15, 2023

Study Completion Date

December 20, 2023

Conditions
Preterm Labor
Interventions
DRUG

human chorionic gonadotropin (hCG)

H.C.G. will be given in Group A and in a dose of 5000units intramuscular injection followed by a drip of 10,000 units in 500ml of dextrose 5%, at the rate of 20 drops per minute.

DRUG

Magnesium sulfate

4gm of MgSO4 will be given in Group B as intravenously as continuous dose followed by 2gm/hr till uterine quiescence is achieved.

Trial Locations (1)

44000

Mother and Child Care Hospital, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad

All Listed Sponsors
lead

Shaheed Zulfiqar Ali Bhutto Medical University

OTHER